How many insider trades does FilingIQ track for MGRX?

FilingIQ tracks 41 Form 4 insider transactions for MGRX (MANGOCEUTICALS, INC.), covering filings from Apr 4, 2023 onwards. 6 of those were filed in the last 90 days.

Are MGRX insiders net buyers or net sellers?

Across the full Form 4 history for MGRX, 1 transactions (2%) were open-market purchases and 6 (15%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MGRX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MGRX in?

MANGOCEUTICALS, INC. (MGRX) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $2.64M.

MGRX insider trading

NasdaqCM Healthcare

MANGOCEUTICALS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

2% / 15%

Market cap

$2.64M

About MANGOCEUTICALS, INC.

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Company website: www.mangoceuticals.com

MGRX insider activity at a glance

FilingIQ has scored 41 insider transactions for MGRX since Apr 4, 2023. The most recent filing in our index is dated Mar 16, 2026.

Across the full history, 1 open-market purchases and 6 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MGRX insider trades is 62.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MGRX trades on FilingIQ Raw filings on SEC EDGAR

Latest MGRX Form 4 filings

JOHNSTON EUGENE M CFO

S Dec 5, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for MGRX?: FilingIQ tracks 41 Form 4 insider transactions for MGRX (MANGOCEUTICALS, INC.), covering filings from Apr 4, 2023 onwards. 6 of those were filed in the last 90 days.
Are MGRX insiders net buyers or net sellers?: Across the full Form 4 history for MGRX, 1 transactions (2%) were open-market purchases and 6 (15%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MGRX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MGRX in?: MANGOCEUTICALS, INC. (MGRX) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $2.64M.

Methodology & sources

Every MGRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.